MaryAStaatMD
Pediatric Infectious Disease • Cincinnati, OHProfessor, Pediatrics, University of Cincinnati College of Medicine
Dr. Staat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML7036
Cincinnati, OH 45229Phone+1 513-636-2877Fax+1 513-636-6936
Education & Training
Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1991 - 1993
Baylor College of Medicine (Houston)Residency, Pediatrics, 1986 - 1989
University of Kentucky College of MedicineClass of 1986
Certifications & Licensure
OH State Medical License 1995 - 2026
KY State Medical License 1995 - 2018
MD State Medical License 1989 - 1995- American Board of Pediatrics Pediatric Infectious Diseases
- American Board of Preventive Medicine Public Health & General Preventive Medicine
Clinical Trials
- Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines Start of enrollment: 2018 Jul 17
- Serology to COVID-19 for Recording Exposures and Evaluating Needs Start of enrollment: 2020 Aug 18
- Observational Maternal COVID-19 Vaccination Study Start of enrollment: 2021 May 24
Roles: Sub-Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems.Anna F Wang-Erickson, Xueyan Zhang, Klancie Dauer, Danielle M Zerr, Amanda Adler
The Pediatric Infectious Disease Journal. 2025-01-01 - Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses.Vamsee Mallajosyula, Saborni Chakraborty, Elsa Sola, Ryan Furuichi Fong, Vishnu Shankar
Science. 2024-12-20 - Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, Geoffrey A Weinberg, Mary A Staat
JAMA Pediatrics. 2024-12-09
Journal Articles
- Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older AdultsKenneth E Schmader, Christine K Liu, Heidi Auerbach, Elizabeth D Barnett, Elizabeth P Schlaudecker, Mary A Staat, JAMA Network Open
Press Mentions
It’s Safe to Give COVID-19 and Influenza Vaccines TogetherNovember 18th, 2024
Family Visits Cincinnati to Thank Doctors That Saved Daughter from Rare VirusAugust 20th, 2024
SARS-CoV-2 Protein Linked to Onset of Multisystem Inflammatory Syndrome in ChildrenAugust 6th, 2024- Join now to see all
Grant Support
- Enhanced Surveillance For New Vaccine Preventable Disease -Patient Protection-AcaNational Center For Immunization And Respiratory Diseases2011
- Enhanced Surveillance For New Vaccine Preventable DiseaseNational Center For Immunization And Respiratory Diseases2011
- Enhanced Surveillance For New Vaccine Preventable DiseasesNational Center For Immunization And Respiratory Diseases2010
- Enhanced Surveillance For New Vaccine Preventable DiseasesNational Center For Immunization And Respiratory Diseases2009
- Enhanced Surveillance For New Vaccine Preventable DiseasesNational Center For Immunization And Respiratory Diseases2007–2008
- Enhanced Surveillance For Newly Vaccine Preventable DiseaseNational Center For Immunization And Respiratory Diseases2005–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
